Shuyu Pingmin disclosed its 2026 semi-annual report on August 26. In the first half, it achieved total operating revenue of 5.314 billion yuan, up 8.86% year on year, but net profit attributable to the parent company was 25.776 million yuan, down 28.90% year on year. Net profit after deducting non-recurring items was 24.7604 million yuan, down 21.51% year on year, and net cash flow from operating activities was 43.701 million yuan, a sharp year-on-year decline of 68.30%. The company's main business is pharmaceutical retail chain operations. During the reporting period, the weighted average return on equity was 1.26%, down 0.63 percentage points year on year. As of the first half of 2026, the company's goodwill reached 2.304 billion yuan, equivalent to 109.54% of net assets in the same period, and the largest shareholder Li Wenjie and the second-largest shareholder Qin Guangxia had pledged 39.3% and 50.84% of their respective shareholdings.
ShuYu Civilian Pharmacy Corp. Ltd.Net profit fell 28.9% year-on-year, with operating cash flow down 68.3%.
